Document is current
Any future updates will be listed below
-
Authors
Havranek, Brandon
Loh, Rebecca
Torre, Beatriz
Redfield, Rachel
Halegoua-DeMarzio, Dina
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 5 February 2025
First Online: 10 February 2025
Declarations
:
: Dina Halegoua-DeMarzio: Consultant- Pfizer. Research Grant Support- Intercept, Galectin, BMS, Novo Nordisk, Viking, Pfizer; however, this article is solely the author’s work without any connection with Pfizer, Intercept, Galectin, BMS, Novo Nordisk, and Viking. All other authors have no conflict of interests.
: Only aggregated counts and statistical summaries of de-identified information without any protected health information are received from participating HCOs, and no study-specific activities are performed in these retrospective analyses; therefore, TriNetX federated network has been granted a waiver from the Western institutional review board, including the Thomas Jefferson institutional review board.
